Media Coverage | Nine News

Avecho was featured on Nine News this weekend, as recruitment for the Company’s pivotal Phase III trial continues. 

Avecho is currently investigating the effectiveness of its proprietary TPM^®-enhanced CBD soft-gel capsule in the treatment of insomnia.

CEO Dr Paul Gavin explained that the Company is seeking to recruit over 500 participants in the trial: 

“We’re hoping to be the first  ones to get it successfully registered, and that’s why our trial is so big, and so rigorous.”

Trial sites are now open in New South Wales, Queensland, Victoria and Western Australia, and are currently recruiting participants who have been diagnosed with insomnia, or who have been struggling with poor sleep for at least three months. 

To learn more about participating in the study, visit: http://cbdinsomniastudy.com/

Watch the Nine news story: